Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01341678 · ClinicalTrials.gov registry record · NA

Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease

A NA study of Chronic Kidney Disease, sponsored by Geoffrey Block.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT01341678 is a NA study of Chronic Kidney Disease that has completed, run by Geoffrey Block. The registered enrollment target is 15 participants, below the 3,207-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01341678, a NA study of Chronic Kidney Disease, has completed, sponsored by Geoffrey Block.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to describe the circadian rhythm of serum and salivary phosphorus in patients with chronic kidney disease and determine its' modification in response to changes in dietary phosphate load.

Conditions Studied

Interventions

  • OTHER Diet Only
  • DRUG Lanthanum Carbonate
  • DIETARY_SUPPLEMENT NeutraPhos

Study Locations (1)

Colorado

  • Denver Nephrologists, PC - Denver

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2011-04
Est. Completion 2011-10
Phase NA

Sponsor

Geoffrey Block

1 total trials

What the Registry Record Tells You About NCT01341678

The ClinicalTrials.gov registry entry for NCT01341678 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,207-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (100% lower). The listed sponsor is Geoffrey Block, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 3 interventions - of which Diet Only is the first listed.

NCT01341678 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT01341678 about?

NCT01341678 is a clinical study titled "Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease". The purpose of this study is to describe the circadian rhythm of serum and salivary phosphorus in patients with chronic kidney disease and determine its' modification in response to changes in dietary phosphate load.

What is the current status of trial NCT01341678?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2011-04. Estimated completion is 2011-10.

What conditions does trial NCT01341678 study?

This clinical trial studies the following conditions: Chronic Kidney Disease.

What interventions are being tested in trial NCT01341678?

The interventions under investigation include: Diet Only (OTHER), Lanthanum Carbonate (DRUG), NeutraPhos (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01341678?

This trial is sponsored by Geoffrey Block, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01341678 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.